معرفی
Fleur Garton is a Research Fellow at the University of Queensland's Queensland Brain Institute, specializing in neurogenetics and genomic medicine. She leads research on the genetic mechanisms underlying Motor Neurone Disease (MND/ALS), leveraging advanced genomic and epigenetic analyses to improve diagnosis and treatment strategies. Her work integrates cell-free DNA, 'omic data, and clinical collaborations to uncover disease pathways.
Dr. Garton holds a Bachelor of Applied Science (Hons I) from the University of Sydney (2008) and a PhD from the Institute of Neuroscience and Muscle Research at Children's Hospital Westmead. She completed postdoctoral training at the Murdoch Childrens Research Institute and the University of Queensland under Prof. Naomi Wray. She has been awarded the NHMRC Early Career Fellowship (2017-2022) and the Scott Sullivan MND Research Fellowship (2022).
Her research focuses on ALS pathogenesis, including metabolic dysfunction, DNA methylation alterations, and novel biomarker discovery. She collaborates with Royal Brisbane and Women’s Hospital, Mater Hospital, and international teams. Key interests include the interplay between genetics, muscle physiology, and neurodegenerative disorders.
- Education:
- Bachelor of Applied Science (Hons I), University of Sydney (2008)
- PhD in Neuroscience, Institute of Neuroscience and Muscle Research (2010s)
- Awards:
- Bill Gole MND Postdoctoral Fellowship (2016)
- NHMRC Early Career Researcher Fellowship (2017-2022)
- Scott Sullivan MND Research Fellowship (2022)
- Grants & Projects: Multiple collaborative projects on ALS diagnostics, funded by MNDRA and NHMRC.
- Labs/Teams: Program in Complex Trait Genomics (UQ), Queensland Brain Institute.
